Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

PaperCitations, authors & open-access status

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 85 citations, 2017 year and bronze oa status.

85
Citations
2017
Year
bronze
OA Status

Related on ScholarIQ

Deven Chauhan
Author
Amyotrophic Lateral Sclerosis Research
Topic
Amyotrophic Lateral Sclerosis Research
Topic
Spondyloarthritis Studies and Treatments
Topic
Peripheral Neuropathies and Disorders
Topic
470M+ articles · free account